Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Obermeier

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Gastroenterology|September 7, 2005
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammationFlorian Obermeier, Nadja Dunger, Ulrike G Strauch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activationLeif E Sander, Florian Obermeier, Uta Dierssen, et al.
Plos One|August 14, 2014
Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort studyFlorian Rieder, Gisela Paul, Elisabeth Schnoy, et al.
Gastroenterology|October 28, 2008
CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance inductionAndre Bleich, Lydia M Janus, Anna Smoczek, et al.
The Journal of Biological Chemistry|June 16, 2011
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cellsMartin Hausmann, Katharina Leucht, Christian Ploner, et al.
European Journal of Immunology|September 19, 2006
IL-15 protects intestinal epithelial cellsFlorian Obermeier, Martin Hausmann, Silvia Kellermeier, et al.
Investigational New Drugs|September 20, 2006
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II studyStefan von Delius, Florian Eckel, Stefan Wagenpfeil, et al.
Inflammatory Bowel Diseases|June 30, 2024
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their PhysiciansAntje Timmer, Johanna Neuser, Dominik de Sordi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Gastroenterology|September 7, 2005
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammationFlorian Obermeier, Nadja Dunger, Ulrike G Strauch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activationLeif E Sander, Florian Obermeier, Uta Dierssen, et al.
Plos One|August 14, 2014
Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort studyFlorian Rieder, Gisela Paul, Elisabeth Schnoy, et al.
Gastroenterology|October 28, 2008
CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance inductionAndre Bleich, Lydia M Janus, Anna Smoczek, et al.
The Journal of Biological Chemistry|June 16, 2011
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cellsMartin Hausmann, Katharina Leucht, Christian Ploner, et al.
European Journal of Immunology|September 19, 2006
IL-15 protects intestinal epithelial cellsFlorian Obermeier, Martin Hausmann, Silvia Kellermeier, et al.
Investigational New Drugs|September 20, 2006
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II studyStefan von Delius, Florian Eckel, Stefan Wagenpfeil, et al.
Inflammatory Bowel Diseases|June 30, 2024
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their PhysiciansAntje Timmer, Johanna Neuser, Dominik de Sordi, et al.
Pageof 5